SCAP and fatty liver disease: Insulin increases the expression of SREBP-1c, it promotes the mobilization of the SREBP-cleavage activating protein (SCAP)/SREBP-1c complex to the Golgi apparatus, SREBP-1c cleavage, and the successive processes leading to hepatic lipogenesis and hepatic steatosis (20).